Loading stock data...
Last Updated: 10 Mar 2026, 03:29:18 PM (IST)

Pharmaids Pharmaceuticals Limited

BSE: PHARMAID

BSE
35.41 1.41 (4.15%)

Prev Close

34

Open Price

35.9

Volume

29,499

Today Low / High

34.25 / 38

52 WK Low / High

30 / 73.45

Range

34 - 37

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 35.41, reflecting a change of 1.41 (4.14706%). The expected target range on the BSE is 34 - 37. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

Pharmaids Pharmaceuticals Limited Graph

Pharmaids Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Pharmaids Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 35.41, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 35.41 35.76 32.19 - 39.34
36.12 28.89 - 43.34
36.47 25.53 - 47.41
Bearish Scenario 35.41 35.06 31.55 - 38.56
34.70 27.76 - 41.64
34.35 24.04 - 44.65

Overview of Pharmaids Pharmaceuticals Limited

ISIN

INE117D01018

Industry

Medical - Pharmaceuticals

Vol.Avg

7,039

Market Cap

1,145,145,856

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

60.89

DCF

-28

Financial Ratios Every Investor Needs

Stock Rating Details for PHARMAID

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 19.51 Cr 2.12 Cr 6.28 Cr 0.3216 0.00 Cr 1.07 Cr -15.20 Cr -10.78 Cr -1.11 -12.83 Cr -0.5523
2024-03-31 14.60 Cr 13.08 Cr 1.52 Cr 0.1041 0.00 Cr 1.37 Cr -14.69 Cr -7.97 Cr -3.51 -12.35 Cr -0.5459
2023-03-31 0.00 Cr 0.89 Cr -0.89 Cr 0.0000 0.00 Cr 1.31 Cr -9.90 Cr -7.56 Cr -5.86 -9.89 Cr 0.0000
2022-03-31 3.94 Cr 3.57 Cr 0.37 Cr 0.0934 0.00 Cr 0.05 Cr 0.13 Cr 0.15 Cr 0.14 0.14 Cr 0.0368
2021-03-31 8.55 Cr 8.16 Cr 0.39 Cr 0.0458 0.00 Cr 0.03 Cr 0.07 Cr 0.09 Cr 0.09 0.13 Cr 0.0109

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.14 Cr 119.85 Cr 64.81 Cr 59.3203 Cr 38.97 Cr 36.83 Cr 12.18 Cr 49.18 Cr 0.00 Cr 0.00 Cr 5.58 Cr 28.7145 Cr
2024-03-31 4.80 Cr 91.34 Cr 20.84 Cr 72.0470 Cr 8.53 Cr 3.73 Cr 3.59 Cr 38.46 Cr 0.05 Cr 0.00 Cr 0.14 Cr 11.5758 Cr
2023-03-31 12.75 Cr 24.59 Cr 2.13 Cr 22.4601 Cr 2.47 Cr -12.75 Cr -0.07 Cr 2.11 Cr 0.00 Cr 0.00 Cr 2.10 Cr 2.1273 Cr
2022-03-31 0.41 Cr 11.11 Cr 2.44 Cr 8.6716 Cr 0.00 Cr -0.41 Cr 0.89 Cr 0.48 Cr 0.00 Cr 0.00 Cr 7.51 Cr 2.4407 Cr
2021-03-31 0.20 Cr 9.12 Cr 0.59 Cr 8.5264 Cr 0.00 Cr -0.20 Cr 0.37 Cr 0.49 Cr 0.00 Cr 0.00 Cr 7.32 Cr 0.5886 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -13.9912 Cr -12.0237 Cr 23.3555 Cr -26.4720 Cr -2.6595 Cr 2.1445 Cr -12.4808 Cr -3.9388 Cr 27.7855 Cr 0.0000 Cr -8.5933 Cr
2024-03-31 -10.6196 Cr -74.9904 Cr 77.6598 Cr -34.5105 Cr -7.9502 Cr 4.8040 Cr -22.8625 Cr -7.9680 Cr -0.2655 Cr 0.0000 Cr 0.7164 Cr
2023-03-31 -4.0193 Cr -4.9433 Cr 21.3094 Cr -5.6922 Cr 12.3468 Cr 12.7542 Cr -1.6729 Cr -9.9076 Cr 0.0000 Cr 0.0000 Cr 0.8876 Cr
2022-03-31 -0.2593 Cr 0.4665 Cr 0.0000 Cr -0.2593 Cr 0.2071 Cr 0.4074 Cr 0.0000 Cr 0.1411 Cr 0.0000 Cr 0.0000 Cr -0.5185 Cr
2021-03-31 0.4053 Cr -0.2268 Cr 0.0000 Cr 0.4038 Cr 0.1785 Cr 0.2003 Cr -0.0015 Cr 0.0933 Cr 0.0000 Cr 0.0000 Cr -0.3691 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 5.43 Cr 6.11 Cr -0.68 Cr -0.1246 -2.98 Cr -2.48 Cr -0.70 -2.50 Cr -0.4565
2025-09-30 8.61 Cr 11.20 Cr -2.59 Cr -0.3014 -5.79 Cr -2.48 Cr -0.70 -2.11 Cr -0.2883
2025-06-30 6.66 Cr 3.51 Cr 3.16 Cr 0.4739 -6.02 Cr -4.95 Cr -1.41 -5.37 Cr -0.7431
2025-03-31 4.77 Cr 4.24 Cr -2.02 Cr -0.4245 -4.53 Cr -3.94 Cr -2.22 -8.37 Cr -0.8261
2024-12-31 4.71 Cr 2.99 Cr 1.72 Cr 0.3647 -3.52 Cr -1.93 Cr -0.55 -2.89 Cr -0.4105

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.24 Cr 0.00 Cr 0.24 Cr 8.70 Cr 4.00 Cr 24.18 Cr 26.48 Cr 98.44 Cr 47.13 Cr
2025-06-30 0.00 Cr 0.00 Cr 2.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -55.04 Cr
2025-03-31 2.14 Cr 0.00 Cr 2.14 Cr 3.13 Cr 12.18 Cr 22.31 Cr 49.18 Cr 119.85 Cr 64.81 Cr
2024-12-31 0.00 Cr 0.00 Cr 2.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -64.82 Cr
2024-09-30 2.79 Cr 0.00 Cr 2.79 Cr 3.26 Cr 2.37 Cr 12.55 Cr 40.47 Cr 94.60 Cr 29.78 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -4.95 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 2.90 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -1.93 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -2.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -2.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹830.35 ₹99,644,807,413.00 ₹76,499.00

Key Executives

Deputy Finance Controller
K. Sree Lekha

Gender: Not Specified

Year Born: 1994

Vice President of Operations
Sidde Gowda

Gender: Not Specified

Year Born:

Assistant Manager of Admin & Purchase
Ingreed Anisha

Gender: Not Specified

Year Born: 1997

Chief Financial Officer
B.C Balagangadhara

Gender: male

Year Born: 1982

Company Secretary & Compliance Officer
Prasanna Subramanya Bhat

Gender: male

Year Born: 1992

Chief Information Officer
Shivananda Murthy V

Gender: male

Year Born:

Executive Director
Venu Madhava Kaparthy

Gender: male

Year Born: 1969

Executive Director
Mini Manikantan

Gender: female

Year Born: 1984

Accounts Officer
R. Mani Bhavani

Gender: female

Year Born:

Scientific General Manager
Prakash Alva

Gender: Not Specified

Year Born: 1976

Senior Manager of Strategy & Operational Excellence
R Iyer Mahadevan

Gender: Not Specified

Year Born: 1969

Manager
Shiva Kumar K. J.

Gender: Not Specified

Year Born: 1978

FAQs about Pharmaids Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is B.C Balagangadhara.

What is the current market price of the stock?

The current price is ₹32.47.

What is the 52-week price range?

The range is ₹30-75.95.

What is the market capitalization of the company?

The market capitalization is ₹114.51 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -8.27.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Pharmaids Pharmaceuticals Limited (ISIN: INE117D01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹114.51 crores and an average daily volume of 7,039 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.